Loading insider details...
Latest Form 4 (Aug 12, 2026): Grant/Award of 60,200 DMAC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 60,200 | n/a |
| Jun 3, 2026 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 380,000 | n/a |
| Jun 3, 2025 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 600,000 | n/a |
| Jun 3, 2024 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 300,000 | n/a |
| Jun 26, 2023 | DiaMedica Therapeutics Inc. (DMAC) | Purchase | 12,787 | $50.0K |
| Jun 2, 2023 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 181,000 | n/a |
| Nov 17, 2022 | DiaMedica Therapeutics Inc. (DMAX) | Purchase | 20,000 | $24.2K |
| Jun 2, 2022 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 177,000 | n/a |
| Aug 16, 2021 | DiaMedica Therapeutics Inc. (DMAC) | Purchase | 5,000 | $15.7K |
| Jul 30, 2021 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 175,000 | n/a |